666

VCANBIO CELL & GENE ENGINEERING

No trades
See on Supercharts
Market capitalization
‪7.31 B‬CNY
‪112.99 M‬CNY
‪1.54 B‬CNY
‪309.47 M‬
Beta (1Y)
1.25

About VCANBIO CELL & GENE ENGINEERING

CEO
Yong Wang
Headquarters
Tianjin
Employees (FY)
‪2.33 K‬
Founded
1993
ISIN
CNE000000545
FIGI
BBG000BFZ7G2
Vcanbio Cell & Gene Engineering Corp., Ltd. engages in the development of life sciences technology. Its business activities include stem cell genetic engineering, venture capital, investment banking, and investment consulting. It also engages in the import and export of goods and technology. The company was founded on May 4, 1993 and is headquartered in Tianjin, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600645 is 16.13 CNY — it has increased by 1.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange VCANBIO CELL & GENE ENGINEERING stocks are traded under the ticker 600645.
600645 stock is 2.80% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is VCANBIO CELL & GENE ENGINEERING there?
Yes, you can track VCANBIO CELL & GENE ENGINEERING financials in yearly and quarterly reports right on TradingView.
600645 stock has risen by 6.40% compared to the previous week, the month change is a 4.22% fall, over the last year VCANBIO CELL & GENE ENGINEERING has showed a 14.02% decrease.
600645 net income for the last quarter is ‪49.84 M‬ CNY, while the quarter before that showed ‪45.30 M‬ CNY of net income which accounts for 10.01% change. Track more VCANBIO CELL & GENE ENGINEERING financial stats to get the full picture.
Today VCANBIO CELL & GENE ENGINEERING has the market capitalization of ‪7.44 B‬, it has increased by 3.64% over the last week.
No, 600645 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 600645 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VCANBIO CELL & GENE ENGINEERING stock right from TradingView charts — choose your broker and connect to your account.
600645 reached its all-time high on Apr 24, 2015 with the price of 79.58 CNY, and its all-time low was 1.24 CNY and was reached on Jul 18, 2005.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪2.33 K‬ employees. See our rating of the largest employees — is VCANBIO CELL & GENE ENGINEERING on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VCANBIO CELL & GENE ENGINEERING technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VCANBIO CELL & GENE ENGINEERING stock shows the sell signal. See more of VCANBIO CELL & GENE ENGINEERING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.